Adaptimmune Therapeutics shares owned by Millennium Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Millennium Management
from 13F filings
Historical chart of Millennium Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Millennium Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $760k | 780k | 0.97 |
| 2024-03-31 | $1.3M | 825k | 1.58 |
| 2023-12-31 | $350k | 441k | 0.79 |
| 2023-09-30 | $234k | 300k | 0.78 |
| 2023-06-30 | $603k | 652k | 0.93 |
| 2023-03-31 | $327k | 300k | 1.09 |
| 2022-12-31 | $240k | 165k | 1.46 |
| 2022-06-30 | $208k | 122k | 1.70 |
| 2022-03-31 | $3.0M | 1.4M | 2.06 |
| 2021-09-30 | $8.2M | 1.6M | 5.17 |
| 2021-06-30 | $4.0M | 930k | 4.26 |
| 2021-03-31 | $8.6M | 1.6M | 5.31 |
| 2020-12-31 | $9.3M | 1.7M | 5.39 |
| 2020-09-30 | $5.6M | 705k | 7.98 |
| 2020-06-30 | $18M | 1.8M | 10.01 |
| 2020-03-31 | $4.0M | 1.5M | 2.72 |
| 2019-12-31 | $592k | 493k | 1.20 |
| 2019-09-30 | $1.4M | 914k | 1.51 |
| 2019-06-30 | $36M | 869k | 41.11 |
| 2019-03-31 | $11M | 2.6M | 4.30 |
| 2018-12-31 | $13M | 2.3M | 5.75 |
| 2018-09-30 | $38M | 2.8M | 13.56 |
| 2018-06-30 | $11M | 944k | 11.87 |
| 2018-03-31 | $17M | 1.5M | 11.23 |
| 2017-12-31 | $5.4M | 806k | 6.68 |
| 2017-09-30 | $4.8M | 590k | 8.19 |
| 2017-06-30 | $1.1M | 248k | 4.49 |
| 2017-03-31 | $4.0M | 720k | 5.51 |
| 2016-12-31 | $2.7M | 672k | 4.05 |
| 2016-09-30 | $4.6M | 647k | 7.05 |
| 2016-06-30 | $5.5M | 675k | 8.15 |
| 2016-03-31 | $7.5M | 917k | 8.13 |
| 2015-12-31 | $4.2M | 345k | 12.06 |
| 2015-09-30 | $2.2M | 188k | 11.97 |
| 2015-06-30 | $2.2M | 118k | 18.33 |